Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study

Lancet

Volumn 361, Issue 9372, 2003, Pages 1843-1848

  Jong, Philip ^a   Yusuf, Salim ^a,d   Rousseau, Michel F ^b   Ahn, Sylvie A ^b   Bangdiwala, Shrikant I ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c IL   (United States)

^d HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART DEATH; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE CONTRACTION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; WILCOXON SIGNED RANKS TEST;

EID: 0037716744     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13501-5     Document Type: Article

References (20)

1. The SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. [published erratum appears in N Engl J Med 1992; 327: 1768]. N Engl J Med 1992; 327: 685-91.
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
3. Yusuf S., Pepine C.J., Garces C., et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 340:1992;1173-1178.
4. Studies of left ventricular dysfunction (SOLVD) rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction [published erratum appears in Am J Cardiol 1990; 66: 1026]. Am J Cardiol 1990; 66: 315-22.
5. National death index user's manual. Hyattsville: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics, 1990. http://www.cdc.gov/nchs/r&d/ndi/ndi.htm (accessed March 19, 2003).
6. The Office of Policy. Announcement of service to epidemiological researchers to provide vital status data on subjects of health research, 4190-29P. http://www.ssa.gov/policy/research/epidemiology.html (accessed March 19, 2003).
7. Smith M.E., Newcombe H. Use of the Canadian mortality data base for epidemiological follow-up. Can J Public Health. 73:1982;39-46.
8. Fair M, Newcombe H, Lalonde P, et al. "Alive" searches as complementing death searches in the epidemiological follow-up of Ontario miners. Ottawa: Atomic Energy Control Board, 1988: INFO-0266.
9. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data. 1980;Riley, New York.
10. Cox D.R. Regression models and life tables. J R Stat Soc. 34:1972;187-200.
11. Torp-Pedersen C., Kober L. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. Lancet. 354:1999;9-12.
12. Simonoff J.S. Smoothing methods in statistics. 1996;Springer, New York.
13. Cohen J.A. A coefficient of agreement for nominal scales. Educ Psychol Meas. 20:1960;37.
14. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Trialists Collaboration. Lancet. 344:1994;563-570.
15. Swedberg K., Kjekshus J., Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril: ten year follow-up of CONSENSUS I. Eur Heart J. 20:1999;136-139.
16. Hall A.S., Murray G.D., Ball S.G. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Lancet. 349:1997;1493-1497.
17. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med. 332:1995;80-85.
18. Shannon H.S., Jamieson E., Walsh C., et al. Comparison of individual follow-up and computerized record linkage using the Canadian Mortality Data Base. Can J Public Health. 80:1989;54-57.
19. Davis K.B. A test of the national death index using the Coronary Artery Surgery Study (CASS). Control Clin Trial. 6:1985;179-191.
20. Rogot E., Feinleib M., Ockay K.A., et al. On the feasibility of linking census samples to the National Death Index for epidemiologic studies: a progress report. Am J Public Health. 73:1983;1265-1269.